Search

everythinglearnresearchcommunity

for

Search:↓

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

Mesenchymal stem cells may effectively treat and prevent allergic skin conditions.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

CRH in the skin acts like the body's stress response system, affecting cell behavior and immune activity.

Allergic contact dermatitis may promote hair growth by activating hair follicle stem cells.

Stem cell therapies show promise for hair regrowth in alopecia areata but need more research for safety and effectiveness.

Androgenetic alopecia involves immune cell disruptions, especially increased CD4+ T cells around hair follicles.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Stress increases nerve fibers and immune cell activity in mouse skin, possibly worsening skin conditions.

TSLP affects atopic dermatitis by increasing sebum and reducing fat through IL-4/IL-13 signaling.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Stem cell transplantation shows promise for treating diseases but faces challenges like safety, ethics, and cost.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Keratinocytes help heal skin wounds by interacting with immune cells and producing substances that kill pathogens.

Small extracellular vesicles from stem and immune cells show promise for treating various diseases but face challenges in clinical use.

Removing Ctip2 in skin cells causes skin inflammation similar to atopic dermatitis.

The skin has a complex immune system that is essential for protection and healing, requiring more research for better wound treatment.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

Developing human skin has immune cells with memory-like features.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Alarmin cytokines are key in controlling skin immunity and inflammation.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

Autoimmune diseases with high tissue recovery often relapse and remit, while those with low recovery rarely remit.

Mouse hair follicle stem cells can help prevent Type 1 Diabetes.

Targeting TRP channels may help reduce excessive scarring.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.